• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Jason Mitchell on Aligning Incentives Across the Entire Healthcare System

Video

One of the most important things you can do to align healthcare strategies in the shift toward value-based care is to allow your clinicians to be part of that journey, explained Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services.

One of the most important things you can do to align healthcare strategies in the shift toward value-based care is to allow your clinicians to be part of that journey, explained Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services.

Transcript

What are some potential strategies for aligning incentives across the entire healthcare system during the shift to value-based care?

I think one of the most important things you can do to align healthcare strategies is to allow your clinicians to be part of that journey. Get your physicians, your nurses, your pharmacists, everybody involved upfront so they can recognize the connection to the care and they can help you understand what you should be doing. The other thing is to make sure your leaders are aligned. As you think about budgets and operating margins, everyone has to first think, “How am I going to give the best care to the patients at the most affordable costs?” If you can get your leaders aligned to that, then they’ll make choices that are aligned with what you want to do as an organization. I think leading with your clinicians and getting all your leaders on board so you’re all moving in the same direction. Keeping your patient or your member at the front is really how you get there.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.